An Examination of the Psychometric Properties and Factor Structure of the Feelings of Stigmatization Questionnaire

  • Anja Wittkowski
  • Helen L. Richards
  • Jennifer Williams
  • Donal G. Fortune
  • Christopher E. M. Griffiths
  • Chris J. Main


As the experience of stigma and its psychological dimensions require careful measurement, the purpose of this study was to examine the psychometric properties and factor structure of the Feelings of Stigmatization Questionnaire (FSQ). A total of 170 participants with psoriasis and 124 with atopic dermatitis (AD) completed the FSQ. AD participants self-rated AD severity, while psoriasis severity was determined by a clinician. Confirmatory (CFA) and exploratory factor analytic (EFA) techniques were used to examine the factor structure of the FSQ. The FSQ total score was not related to age, age at onset, illness duration or psoriasis severity but it was negatively associated with AD severity (r = −.25, p < .01). The original six-factor structure of the FSQ was not replicated in our sample. Using EFA, a fixed three-factor solution proved the most stable, with the dimensions of feeling flawed, anticipation of rejection and secrecy, and positive attitudes towards skin disease being identified.


Atopic dermatitis Psoriasis Stigmatization Measurement 


  1. Barrowclough, C., Tarrier, N., Humphreys, L., Ward, J., Gregg, L., & Andrews, B. (2003). Self-esteem in schizophrenia: Relationships between self-evaluation, family attitudes, and symptomatology. Journal of Abnormal Psychology, 112, 92–99.PubMedCrossRefGoogle Scholar
  2. Bentler, P. M. (1990). Comparative fit indexes in structural models. Psychological Bulletin, 107, 238–246.PubMedCrossRefGoogle Scholar
  3. Calhoun, L., & Tedeshi, R. (1999). Facilitating posttraumatic growth: A clinician’s guide. Mahwah, NJ: Lawrence Erlbaum Associates.Google Scholar
  4. Catell, R. B. (1965). Factor analysis and introduction to essentials: The purpose and underlying models. Biometrics, 21, 190–215.CrossRefGoogle Scholar
  5. Corrigan, P. W. (2000). Mental health stigma as social attribution: Implications for research methods and attitude change. Clinical Psychology Science Practice 7, 48–67.CrossRefGoogle Scholar
  6. Fan, X., Thompson, B., & Wang, L. (1999). The effects of sample size, estimation methods, and model specification on SEM fit indices. Structural Equation Modeling, 6, 56–83.CrossRefGoogle Scholar
  7. Feldman, S. R., Fleischer, A. B., Reboussin, D. M., Rapp, S. R., Exum, M. L., Clark, A. R., et al. (1996). The self-administered psoriasis area and severity index is valid and reliable. Journal of Investigative Dermatology, 106, 183–186.PubMedCrossRefGoogle Scholar
  8. Feldman, S. R., Fleischer, A. B., & Rapp, S. R. (1997). The self-administered psoriasis area and severity index. Retinoids, 13, 64–65.Google Scholar
  9. Field, A. (2005). Discovering statistics using SPSS, (2nd ed.). London: Sage Publications Limited.Google Scholar
  10. Fleischer, A. B., Rapp, S. R., Reboussin, D., Vanarthos, J. C., & Feldman, S. R. (1994). Patient measure of psoriasis severity with a structured assessment. Journal of Investigative Dermatology, 102, 967–969.PubMedCrossRefGoogle Scholar
  11. Fortune, D. G., Main, C. J., O’Sullivan, T. M., & Griffiths, C. E. M. (1997). Quality of life in patients with psoriasis: The contribution of clinical variables and psoriasis specific stress. British Journal of Dermatology, 137, 755–760.PubMedCrossRefGoogle Scholar
  12. Fortune, D. G., Richards, H. L., Main, C. J., & Griffiths, C. E. M. (1998). What patients with psoriasis believe about their condition. Journal of the American Academy of Dermatology, 39, 196–201.PubMedCrossRefGoogle Scholar
  13. Fortune, D. G., Richards, H. L., Main, C. J., Kirby, B., Bowcock, S., & Griffiths, C. E. M. (2002). A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. British Journal of Dermatology, 146, 458–465.PubMedCrossRefGoogle Scholar
  14. Fortune, D. G., Richards, H. L., Main, C. J., & Griffiths, C. E. M. (2004). Targeting cognitive-behavioural therapy to patients’ implicit models of psoriasis: Results from a patient preference controlled trial. British Journal of Clinical Psychology, 43, 65–82.PubMedCrossRefGoogle Scholar
  15. Fortune, D. G., Richards, H. L., Griffiths, C. E. M., & Main, C. J. (2005). Adversarial growth in patients undergoing treatment for psoriasis: A prospective study of the ability of patients to construe benefits from negative events. Psychology Health and Medicine, 10, 44–56.CrossRefGoogle Scholar
  16. Fredriksson, T., & Pettersson, U. (1978). Severe psoriasis: Oral therapy with a new retinoid. Dermatologica, 157, 238–244.PubMedGoogle Scholar
  17. Ginsburg, I. H., & Link, B. G. (1989). Feelings of stigmatization in patients with psoriasis. Journal of the American Academy of Dermatology, 20, 53–63.PubMedCrossRefGoogle Scholar
  18. Ginsburg, I. H., & Link, B. G. (1993). Psychosocial consequences of rejection and stigma feelings in psoriasis patients. International Journal of Dermatology, 32, 587–591.PubMedCrossRefGoogle Scholar
  19. Goffman, E. (1963). Stigma: Notes on the management of spoiled identity. Englewood Cliffs, NJ: Prentice-Hall.Google Scholar
  20. Hu, L., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6, 1–55.Google Scholar
  21. Jacoby, A. (1994). Felt versus enacted stigma: A concept revisited. Evidence from a study of people with epilepsy in remission. Society Science Medicine, 34, 269–274.CrossRefGoogle Scholar
  22. Jowett, S., & Ryan, T. (1985). Skin disease and handicap: An analysis of the impact of skin conditions. Society Science Medicine, 20, 425–429.CrossRefGoogle Scholar
  23. Kent, G. (1999). Correlates of perceived stigma in vitiligo. Psychology & Health, 14, 241–251.Google Scholar
  24. Kent, G., & Al-Abadie, M. (1996). Factors affecting responses on dermatology life quality index items among vitiligo sufferers. Clinical Experimental Dermatology, 21, 330–333.CrossRefGoogle Scholar
  25. Kim, J. O., & Meuller, C. W. (1978). Factor analysis: Statistical methods and practical issues. London: Sage Publications Inc.Google Scholar
  26. Kline, P. (1994). An easy guide to factor analysis. London: Routledge.Google Scholar
  27. Lob-Corzilius, T., Boer, S., Scheewe, S., Wilke, K., Schon, M., Schule im Walde, J., et al. (2004). The ‘Skin Detective Questionnaire’: A survey tool for self-assessment of patients with atopic dermatitis. First results of its application. Dermatologica Psychosomatica, 5, 141–146.CrossRefGoogle Scholar
  28. Lu, Y., Duller, P., van der Valk, P. G. M., & Evers, A. W. M. (2003). Helplessness as predictor of perceived stigmatization in patient with psoriasis and atopic dermatitis. Dermatologica Psychosomatica, 4, 146–150.CrossRefGoogle Scholar
  29. Marsh, H. W. (1996). Positive and negative global self-esteem: A substantively meaningful distinction or artifactors? Journal of Social Psychology, 70, 810–819.Google Scholar
  30. Perrott, S. B., Murray, A. H., Lowe, J., & Mathieson, C. M. (2000). The psychosocial impact of psoriasis: Physical severity, quality of life, and stigmatization. Physiology Behaviour, 70, 567–571.CrossRefGoogle Scholar
  31. Pett, M. A., Lackey, N. R., & Sullivan, J. J. (2003). Making sense of factor analysis: The use of factor analysis for instrument development in health care research. Thousand Oaks: Sage Publications Inc.Google Scholar
  32. Richards, H. L., Fortune, D. G., Griffiths, C. E., & Main, C. J. (2001). The contribution of perceptions of stigmatization to disability in patients with psoriasis. Journal of Psychosomatic Research, 50, 11–15.PubMedCrossRefGoogle Scholar
  33. Richards, H. L., Fortune, D. G., Chong, S., Mason, D. L., Sweeney, S., Main, C. J., et al. (2004). Divergent beliefs about psoriasis are associated with increased psychological distress. Journal of Investigative Dermatology, 123, 122–130.CrossRefGoogle Scholar
  34. Richards, H. L., Fortune, D. G., Griffiths, C. E. M., & Main, C. J. (2005). Alexithymia in patients with psoriasis: Clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20. Journal of Psychosomatic Research, 58, 89–96.PubMedCrossRefGoogle Scholar
  35. Scambler, G., & Hopkins, A. (1986). Being epileptic: Coming to terms with stigma. Sociology Health Illness, 8, 26–43. .CrossRefGoogle Scholar
  36. Schmid-Ott, G., Jäger, B., Ott, R., & Lamprecht, F. (1996). Dimensions of stigmatization in patients with psoriasis in a questionnaire on experience with skin complaints. Dermatology, 193, 304–310.PubMedGoogle Scholar
  37. Schmid-Ott, G., Jäger, B., Künsebeck, H. W., Ott, R., Wedderer, K., & Lamprecht, F. (1998). Psychosocial influences on the illness experience of psoriasis patients. A study with the “Questionnaire on Experience with Skin Complaints [QES]”. Zeitschrift fürKlinische Psychologie,Psychiatrie und Psychotherapie, 46, 330–343.Google Scholar
  38. Schmid-Ott, G., Künsebeck, H. W., Jäger, B., Werfel, T., Frahm, K., Ruitman, J., et al. (1999). Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients. Acta Dermatological Venereologica, 79, 1–5.CrossRefGoogle Scholar
  39. Schmid-Ott, G., Burchard, R., Niederauer, H. H., Lamprecht, F., & Künsebeck, H. W. (2003). Stigmatization and quality of life of patients with psoriasis and atopic dermatitis. Hautarzt, 54, 852–857.PubMedCrossRefGoogle Scholar
  40. de Turner, S., & Cox, H. (2004). Facilitating post traumatic growth. Health Quality Life Outcomes, 2, 34.
  41. Vardy, D., Besser, A., Amir, M., Gesthalter, B., Biton, A., & Buskila, D. (2002). Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. British Journal of Dermatology, 147, 736–742.PubMedCrossRefGoogle Scholar
  42. Wittkowski, A. (2000). Research into the impact of eczema on the quality of life. Exchange, 98, 22–23.Google Scholar
  43. Wittkowski, A. (2001). An investigation into predictors of quality of life in adults with atopic dermatitis. Unpublished Clin. Psy. D. thesis. University of Manchester, UK.Google Scholar
  44. Wittkowski, A., & Richards, H. L. (2007). How beneficial is cognitive behaviour therapy in the treatment of atopic dermatitis: Reports from two single case designs. Psychology Health & Medicine, 12, 445–449.CrossRefGoogle Scholar
  45. Wittkowski, A., Richards, H. L., Griffiths, C. E. M., & Main, C. J. (2004). The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. Journal of Psychosomatic Research, 57, 195–200.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Anja Wittkowski
    • 1
  • Helen L. Richards
    • 1
  • Jennifer Williams
    • 1
  • Donal G. Fortune
    • 2
  • Christopher E. M. Griffiths
    • 3
  • Chris J. Main
    • 4
  1. 1.Division of Clinical Psychology, School of Psychological SciencesUniversity of ManchesterManchesterUK
  2. 2.Fortune Psychological ConsultingCorkRepublic of Ireland
  3. 3.Dermatological SciencesUniversity of ManchesterManchesterUK
  4. 4.Calderbank Research UnitKeele UniversityStaffordshireUK

Personalised recommendations